Literature DB >> 16338116

Phenotypic and genetic characterization of the Atp7a(Mo-Tohm) mottled mouse: a new murine model of Menkes disease.

Yasumasa Mototani1, Ichiro Miyoshi, Tadashi Okamura, Takuya Moriya, Yan Meng, Xiang Yuan Pei, Satomi Kameo, Noriyuki Kasai.   

Abstract

Mottled Tohoku (Atp7a(Mo-Tohm) or Mo(Tohm)) is an X-linked mutation with mottled pigmentation in heterozygous (Mo(Tohm)/+) females and is embryonic lethal at E11 in hemizygous (Mo(Tohm)/Y) males. Copper levels were low in the brain and high in the intestine of Mo(Tohm) mice. Two congenic strains with ICR or C57BL/6 (B6) background were produced for genetic and phenotypic analyses and revealed that Mo(Tohm)/+ females with ICR background survived until adulthood, while most with B6 background died within 2 days after birth. The Mo(Tohm)/Y males with both backgrounds died at around E11. Massive hemorrhage was shown in the yolk sac cavity with irregular attachment between the mesoderm and the endothelial cells of blood vessels in the embryos at E10.5, suggesting that this irregular attachment causes embryonic lethality. The Mo(Tohm) mutant had a 1440-bp deletion between intron 22 and exon 23 of the Atp7a gene. Mo(Tohm)/Y males with the wild-type Atp7a cDNA transgene were rescued from embryonic lethality, confirming that the Mo(Tohm) mutant is caused by the defect in the Atp7a gene. This mutant mouse is the most severe model of human Menkes disease in mottled mice established to date and one of the useful models for understanding the gene function of Menkes disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16338116     DOI: 10.1016/j.ygeno.2005.09.011

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  9 in total

Review 1.  Menkes disease.

Authors:  Zeynep Tümer; Lisbeth B Møller
Journal:  Eur J Hum Genet       Date:  2009-11-04       Impact factor: 4.246

Review 2.  ATP7A-related copper transport diseases-emerging concepts and future trends.

Authors:  Stephen G Kaler
Journal:  Nat Rev Neurol       Date:  2011-01       Impact factor: 42.937

Review 3.  Molecular pathogenesis of Wilson and Menkes disease: correlation of mutations with molecular defects and disease phenotypes.

Authors:  P de Bie; P Muller; C Wijmenga; L W J Klomp
Journal:  J Med Genet       Date:  2007-08-23       Impact factor: 6.318

4.  Maternofetal and neonatal copper requirements revealed by enterocyte-specific deletion of the Menkes disease protein.

Authors:  Yanfang Wang; Sha Zhu; Victoria Hodgkinson; Joseph R Prohaska; Gary A Weisman; Jonathan D Gitlin; Michael J Petris
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-10-11       Impact factor: 4.052

Review 5.  Animal Models of Normal and Disturbed Iron and Copper Metabolism.

Authors:  Xiaoyu Wang; Michael D Garrick; James F Collins
Journal:  J Nutr       Date:  2019-12-01       Impact factor: 4.798

6.  Increased frequency of congenital heart defects in Menkes disease.

Authors:  Julia D Hicks; Anthony Donsante; Tyler M Pierson; Matthew J Gillespie; Denise E Chou; Stephen G Kaler
Journal:  Clin Dysmorphol       Date:  2012-04       Impact factor: 0.884

7.  Conditional knockout of the Menkes disease copper transporter demonstrates its critical role in embryogenesis.

Authors:  Yanfang Wang; Sha Zhu; Gary A Weisman; Jonathan D Gitlin; Michael J Petris
Journal:  PLoS One       Date:  2012-08-10       Impact factor: 3.240

8.  In vivo function and evolution of the eutherian-specific pluripotency marker UTF1.

Authors:  Masazumi Nishimoto; Miyuki Katano; Toshiyuki Yamagishi; Tomoaki Hishida; Masayoshi Kamon; Ayumu Suzuki; Masataka Hirasaki; Yoko Nabeshima; Yo-ichi Nabeshima; Yukako Katsura; Yoko Satta; Janine E Deakin; Jennifer A Marshall Graves; Yoko Kuroki; Ryuichi Ono; Fumitoshi Ishino; Masatsugu Ema; Satoru Takahashi; Hidemasa Kato; Akihiko Okuda
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

Review 9.  Mottled Mice and Non-Mammalian Models of Menkes Disease.

Authors:  Małgorzata Lenartowicz; Wojciech Krzeptowski; Paweł Lipiński; Paweł Grzmil; Rafał Starzyński; Olga Pierzchała; Lisbeth Birk Møller
Journal:  Front Mol Neurosci       Date:  2015-12-18       Impact factor: 5.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.